Literature DB >> 7974513

Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver.

G M Bogdan1, A Sampayo-Reyes, H V Aposhian.   

Abstract

It is well known that arsenite/arsenate (As3+/As5+) administered to rabbits is bound initially to cellular proteins of the liver before methylated arsenic metabolites appear in urine. This protein binding may decrease the in situ toxicity of inorganic arsenic by decreasing its metabolic availability until it is methylated enzymatically. We have investigated the binding of As3+ and As5+ to the cytosolic proteins of rabbit liver. The results indicate that when cytosolic proteins are incubated with inorganic arsenic, the amount of As3+ bound is 13 times greater than that for As5+. Arsenite-specific binding sites on cytosolic proteins were determined to be 67% of the total (specific and non-specific) number of possible binding sites. Ammonium sulfate fractionation, non-denaturing PAGE and gel filtration chromatography indicate that three liver proteins with molecular weights of 100 kDa, 450 kDa and > 2000 kDa strongly bind arsenite. The radioactive profiles after gel filtration chromatography of liver cytosolic proteins are very similar whether As3+ binding occurs in vitro or in vivo. Thus, the in vitro model appears to be valid for further study of these arsenite-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7974513     DOI: 10.1016/0300-483x(94)90077-9

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  7 in total

1.  Urine arsenic and prevalent albuminuria: evidence from a population-based study.

Authors:  Laura Y Zheng; Jason G Umans; Maria Tellez-Plaza; Fawn Yeh; Kevin A Francesconi; Walter Goessler; Ellen K Silbergeld; Eliseo Guallar; Barbara V Howard; Virginia M Weaver; Ana Navas-Acien
Journal:  Am J Kidney Dis       Date:  2012-11-09       Impact factor: 8.860

2.  Identification of arsenic-binding proteins in human breast cancer cells.

Authors:  Xinyan Zhang; Fan Yang; Joong-Youn Shim; Kenneth L Kirk; D Eric Anderson; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2007-05-17       Impact factor: 8.679

3.  Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments.

Authors:  Michael R Easterling; Miroslav Styblo; Marina V Evans; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-06       Impact factor: 2.745

4.  Identification of galectin I and thioredoxin peroxidase II as two arsenic-binding proteins in Chinese hamster ovary cells.

Authors:  Kwang Ning Chang; Te Chang Lee; Ming F Tam; Yi Chin Chen; Li Wen Lee; Shin Ying Lee; Pei Jung Lin; Rong Nan Huang
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

Review 5.  Arsenic binding to proteins.

Authors:  Shengwen Shen; Xing-Fang Li; William R Cullen; Michael Weinfeld; X Chris Le
Journal:  Chem Rev       Date:  2013-06-28       Impact factor: 60.622

Review 6.  Metabolism, toxicity and anticancer activities of arsenic compounds.

Authors:  Islam Khairul; Qian Qian Wang; Yu Han Jiang; Chao Wang; Hua Naranmandura
Journal:  Oncotarget       Date:  2017-04-04

7.  Methylation study of a population environmentally exposed to arsenic in drinking water.

Authors:  C Hopenhayn-Rich; M L Biggs; A H Smith; D A Kalman; L E Moore
Journal:  Environ Health Perspect       Date:  1996-06       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.